FDA — authorised 23 January 1950
- Status: approved
🇺🇸 Aureomycin in United States
FDA authorised Aureomycin on 23 January 1950
Marketing authorisations
FDA — authorised 23 January 1950
- Application: NDA050404
- Marketing authorisation holder: LEDERLE
- Local brand name: AUREOMYCIN
- Indication: OINTMENT — OPHTHALMIC
- Status: approved
Aureomycin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Aureomycin approved in United States?
Yes. FDA authorised it on 23 January 1950; FDA authorised it on 23 January 1950.
Who is the marketing authorisation holder for Aureomycin in United States?
Marketing authorisation holder not available in our data.